Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Mental Healthcare Act, 2017 and homeless persons with mental illness in India.

Swaminath G, Enara A, Rao R, Kumar KVK, Kumar CN.

Indian J Psychiatry. 2019 Apr;61(Suppl 4):S768-S772. doi: 10.4103/psychiatry.IndianJPsychiatry_117_19. Review.

2.

Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates.

Brown SP, Dransfield P, Vimolratana M, Zhu L, Luo J, Zhang J, Jiao X, Pattaropong V, Wong S, Zhuang R, Swaminath G, Houze JB, Lin DC.

ACS Med Chem Lett. 2018 Jun 6;9(7):757-760. doi: 10.1021/acsmedchemlett.8b00213. eCollection 2018 Jul 12.

3.

Structural Basis for Apelin Control of the Human Apelin Receptor.

Ma Y, Yue Y, Ma Y, Zhang Q, Zhou Q, Song Y, Shen Y, Li X, Ma X, Li C, Hanson MA, Han GW, Sickmier EA, Swaminath G, Zhao S, Stevens RC, Hu LA, Zhong W, Zhang M, Xu F.

Structure. 2017 Jun 6;25(6):858-866.e4. doi: 10.1016/j.str.2017.04.008. Epub 2017 May 18.

4.

Mirtazapine Induced Akathisia: Understanding a Complex Mechanism.

Raveendranathan D, Swaminath GR.

Indian J Psychol Med. 2015 Oct-Dec;37(4):474-5. doi: 10.4103/0253-7176.168615. No abstract available.

5.

Indian Psychiatric Society-South Zone: Innovations and Challenges in Providing Psychiatric Services to Disadvantaged Populations: A Pilgrim's Progress.

Swaminath G.

Indian J Psychol Med. 2015 Apr-Jun;37(2):122-30. doi: 10.4103/0253-7176.155607. No abstract available.

6.

A comparative study of the clinical efficacy and safety of Lorazepam and chlordiazepoxide in alcohol dependence syndrome.

Ramanujam R, L P, G S, Thimmaiah RS.

J Clin Diagn Res. 2015 Mar;9(3):FC10-3. doi: 10.7860/JCDR/2015/11887.5678. Epub 2015 Mar 1.

7.

Optimization of GPR40 Agonists for Type 2 Diabetes.

Liu JJ, Wang Y, Ma Z, Schmitt M, Zhu L, Brown SP, Dransfield PJ, Sun Y, Sharma R, Guo Q, Zhuang R, Zhang J, Luo J, Tonn GR, Wong S, Swaminath G, Medina JC, Lin DC, Houze JB.

ACS Med Chem Lett. 2014 Feb 6;5(5):517-21. doi: 10.1021/ml400501x. eCollection 2014 May 8.

8.

Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists.

Du X, Dransfield PJ, Lin DC, Wong S, Wang Y, Wang Z, Kohn T, Yu M, Brown SP, Vimolratana M, Zhu L, Li AR, Su Y, Jiao X, Liu JJ, Swaminath G, Tran T, Luo J, Zhuang R, Zhang J, Guo Q, Li F, Connors R, Medina JC, Houze JB.

ACS Med Chem Lett. 2014 Feb 3;5(4):384-9. doi: 10.1021/ml4005123. eCollection 2014 Apr 10.

9.

Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles.

Wang Y, Liu JJ, Dransfield PJ, Zhu L, Wang Z, Du X, Jiao X, Su Y, Li AR, Brown SP, Kasparian A, Vimolratana M, Yu M, Pattaropong V, Houze JB, Swaminath G, Tran T, Nguyen K, Guo Q, Zhang J, Zhuang R, Li F, Miao L, Bartberger MD, Correll TL, Chow D, Wong S, Luo J, Lin DC, Medina JC.

ACS Med Chem Lett. 2013 May 7;4(6):551-5. doi: 10.1021/ml300427u. eCollection 2013 Jun 13.

10.

Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1.

Xiong Y, Swaminath G, Cao Q, Yang L, Guo Q, Salomonis H, Lu J, Houze JB, Dransfield PJ, Wang Y, Liu JJ, Wong S, Schwandner R, Steger F, Baribault H, Liu L, Coberly S, Miao L, Zhang J, Lin DC, Schwarz M.

Mol Cell Endocrinol. 2013 Apr 30;369(1-2):119-29. doi: 10.1016/j.mce.2013.01.009. Epub 2013 Feb 9.

PMID:
23403053
11.

A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents.

Luo J, Swaminath G, Brown SP, Zhang J, Guo Q, Chen M, Nguyen K, Tran T, Miao L, Dransfield PJ, Vimolratana M, Houze JB, Wong S, Toteva M, Shan B, Li F, Zhuang R, Lin DC.

PLoS One. 2012;7(10):e46300. doi: 10.1371/journal.pone.0046300. Epub 2012 Oct 9.

12.

Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.

Brown SP, Dransfield PJ, Vimolratana M, Jiao X, Zhu L, Pattaropong V, Sun Y, Liu J, Luo J, Zhang J, Wong S, Zhuang R, Guo Q, Li F, Medina JC, Swaminath G, Lin DC, Houze JB.

ACS Med Chem Lett. 2012 Aug 15;3(9):726-30. doi: 10.1021/ml300133f. eCollection 2012 Sep 13.

13.

Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.

Lin DC, Guo Q, Luo J, Zhang J, Nguyen K, Chen M, Tran T, Dransfield PJ, Brown SP, Houze J, Vimolratana M, Jiao XY, Wang Y, Birdsall NJ, Swaminath G.

Mol Pharmacol. 2012 Nov;82(5):843-59. doi: 10.1124/mol.112.079640. Epub 2012 Aug 2.

14.

Signaling property study of adhesion G-protein-coupled receptors.

Gupte J, Swaminath G, Danao J, Tian H, Li Y, Wu X.

FEBS Lett. 2012 Apr 24;586(8):1214-9. doi: 10.1016/j.febslet.2012.03.014. Epub 2012 Mar 21.

15.

AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents.

Lin DC, Zhang J, Zhuang R, Li F, Nguyen K, Chen M, Tran T, Lopez E, Lu JY, Li XN, Tang L, Tonn GR, Swaminath G, Reagan JD, Chen JL, Tian H, Lin YJ, Houze JB, Luo J.

PLoS One. 2011;6(11):e27270. doi: 10.1371/journal.pone.0027270. Epub 2011 Nov 8.

16.

Medical errors II, the aftermath: Mea culpa!

Swaminath G, Raguram R.

Indian J Psychiatry. 2011 Jan;53(1):9-12. doi: 10.4103/0019-5545.75547. No abstract available.

17.

Mutational analysis of G-protein coupled receptor--FFA2.

Swaminath G, Jaeckel P, Guo Q, Cardozo M, Weiszmann J, Lindberg R, Wang Y, Schwandner R, Li Y.

Biochem Biophys Res Commun. 2011 Feb 4;405(1):122-7. doi: 10.1016/j.bbrc.2010.12.139. Epub 2011 Jan 7.

PMID:
21216233
18.

Medical errors - I : The problem.

Swaminath G, Raguram R.

Indian J Psychiatry. 2010 Apr;52(2):110-2. doi: 10.4103/0019-5545.64580. No abstract available.

19.

Allosteric rescuing of loss-of-function FFAR2 mutations.

Swaminath G, Jaeckel P, Guo Q, Cardozo M, Weiszmann J, Lindberg R, Wang Y, Schwandner R, Li Y.

FEBS Lett. 2010 Oct 8;584(19):4208-14. doi: 10.1016/j.febslet.2010.09.007. Epub 2010 Sep 17.

20.

Going beyond psychopathology-positive emotions and psychological resilience.

Swaminath G, Ravi Shankar Rao BR.

Indian J Psychiatry. 2010 Jan;52(1):6-8. doi: 10.4103/0019-5545.58887. No abstract available.

21.

'Cinemadness': In search of sanity in films.

Swaminath G, Bhide A.

Indian J Psychiatry. 2009 Oct-Dec;51(4):244-6. doi: 10.4103/0019-5545.58287. No abstract available.

22.

Indian Psychiatry and Indian Journal of Psychiatry - A journey.

Rao TS, Swaminath G, Rao GP.

Indian J Psychiatry. 2010 Jan;52(Suppl 1):S1-6. doi: 10.4103/0019-5545.69194. No abstract available.

23.

Psychoeducation.

Swaminath G.

Indian J Psychiatry. 2009 Jul-Sep;51(3):171-2. doi: 10.4103/0019-5545.55082. No abstract available.

24.

Stickiness of the blues: Chronicity of depression.

Swaminath G.

Indian J Psychiatry. 2009 Apr;51(2):82-4. doi: 10.4103/0019-5545.49445. No abstract available.

25.

Faking it - I The Menace of Counterfeit Drugs.

Swaminath G.

Indian J Psychiatry. 2008 Oct;50(4):238-40. doi: 10.4103/0019-5545.44743. No abstract available.

26.

Faking it - II: Countering and preventing counterfeiting of drugs.

Swaminath G.

Indian J Psychiatry. 2009 Jan;51(1):9-11. doi: 10.4103/0019-5545.44899. No abstract available.

27.

Fatty acid binding receptors and their physiological role in type 2 diabetes.

Swaminath G.

Arch Pharm (Weinheim). 2008 Dec;341(12):753-61. doi: 10.1002/ardp.200800096. Review.

PMID:
19009545
28.

Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.

Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J, Jaeckel P, Ge H, Wang Y, Jiao X, Liu J, Kayser F, Tian H, Li Y.

Mol Pharmacol. 2008 Dec;74(6):1599-609. doi: 10.1124/mol.108.049536. Epub 2008 Sep 25.

PMID:
18818303
30.

Internet addiction disorder: Fact or Fad? Nosing into Nosology.

Swaminath G.

Indian J Psychiatry. 2008 Jul;50(3):158-60. doi: 10.4103/0019-5545.43622. No abstract available.

31.

The doctor's dilemma: Truth telling.

Swaminath G.

Indian J Psychiatry. 2008 Apr;50(2):83-4. doi: 10.4103/0019-5545.42392. No abstract available.

32.

Cough up for just a cup of coffee: Pharmacoeconomics of depression.

Swaminath G.

Indian J Psychiatry. 2008 Jan;50(1):5-6. doi: 10.4103/0019-5545.39751. No abstract available.

33.

You can lead a horse to the water....

Swaminath G.

Indian J Psychiatry. 2007 Oct;49(4):228-30. doi: 10.4103/0019-5545.37660. No abstract available.

34.

They also serve who stand and wait.....

Swaminath G.

Indian J Psychiatry. 2007 Oct;49(4):227. doi: 10.4103/0019-5545.37659. No abstract available.

35.

Doctor-patient communication: Patient perception.

Swaminath G.

Indian J Psychiatry. 2007 Jul;49(3):150-3. doi: 10.4103/0019-5545.37309. No abstract available.

36.

The show goes on....

Swaminath G.

Indian J Psychiatry. 2007 Jul;49(3):149. doi: 10.4103/0019-5545.37308. No abstract available.

37.

'Joke's A Part': In defence of humour.

Swaminath G.

Indian J Psychiatry. 2006 Jul;48(3):177-80. doi: 10.4103/0019-5545.31581. No abstract available.

38.

Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.

Yao X, Parnot C, Deupi X, Ratnala VR, Swaminath G, Farrens D, Kobilka B.

Nat Chem Biol. 2006 Aug;2(8):417-22. Epub 2006 Jun 25.

PMID:
16799554
39.

Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.

Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L.

J Biol Chem. 2006 Aug 4;281(31):22021-8. Epub 2006 Jun 5.

40.

Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists.

Swaminath G, Deupi X, Lee TW, Zhu W, Thian FS, Kobilka TS, Kobilka B.

J Biol Chem. 2005 Jun 10;280(23):22165-71. Epub 2005 Apr 7.

41.

A fluorescent probe designed for studying protein conformational change.

Cohen BE, Pralle A, Yao X, Swaminath G, Gandhi CS, Jan YN, Kobilka BK, Isacoff EY, Jan LY.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):965-70. Epub 2005 Jan 18.

42.

Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.

Swaminath G, Xiang Y, Lee TW, Steenhuis J, Parnot C, Kobilka BK.

J Biol Chem. 2004 Jan 2;279(1):686-91. Epub 2003 Oct 14.

43.

Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor.

Swaminath G, Lee TW, Kobilka B.

J Biol Chem. 2003 Jan 3;278(1):352-6. Epub 2002 Oct 29.

44.

Allosteric modulation of beta2-adrenergic receptor by Zn(2+).

Swaminath G, Steenhuis J, Kobilka B, Lee TW.

Mol Pharmacol. 2002 Jan;61(1):65-72.

PMID:
11752207
45.

Predicting the Outcome of Endogenous Depression Following Electroconvulsive Therapy.

Andrade C, Gangadhar BN, Swaminath G, Channabasavanna SM.

Convuls Ther. 1988;4(2):169-174.

PMID:
11940958
46.

Mania as a Side Effect of Electroconvulsive Therapy.

Andrade C, Gangadhar BN, Swaminath G, Channabasavanna SM.

Convuls Ther. 1988;4(1):81-83.

PMID:
11940945
47.

Unilateral brief-pulse ECT and bilateral sinusoidal ECT.

Andrade C, Swaminath G, Gangadhar BN.

J Clin Psychiatry. 1987 Jan;48(1):38-9. No abstract available.

PMID:
3804987

Supplemental Content

Loading ...
Support Center